Benaroya Research Institute in Seattle is internationally recognized for its demonstrated success in diabetes research. The Diabetes Clinical Research Unit (DCRU) utilizes a dedicated six-bed unit for patients and families participating in research studies and clinical trials focused on positively affecting people's diabetes care.
Studies conducted at the DCRU aim to stop the type 1 diabetes disease process at its outset, and provide patients with type 2 diabetes new treatments or therapies that may stimulate more insulin production or enhance the body's ability to better use the insulin that it already produces.